Using temporal orientation, category fluency, and word recall for detecting cognitive impairment: the 10-point cognitive screener (10-CS)

Carregando...
Imagem de Miniatura
Citações na Scopus
63
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Citação
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v.31, n.1, p.4-12, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: A screening strategy composed of three-item temporal orientation and three-word recall has been increasingly used for detecting cognitive impairment. However, the intervening task administered between presentation and recall has varied. We evaluated six brief tasks that could be useful as intervening distractors and possibly provide incremental accuracy: serial subtraction, clock drawing, category fluency, letter fluency, timed visual detection, and digits backwards. Methods: Older adults (n = 230) consecutively referred for suspected cognitive impairment underwent a comprehensive assessment for gold-standard diagnosis, of whom 56 (24%) presented cognitive impairment not dementia and 68 (30%) presented dementia. Among those with dementia, 87% presented very mild or mild stages (Clinical Dementia Rating 0.5 or 1). The incremental value of each candidate intervening task in a model already containing orientation and word recall was assessed. Results: Category fluency (animal naming) presented the highest incremental value among the six candidate intervening tasks. Reclassification analyses revealed a net gain of 12% among cognitively impaired and 17% among normal participants. A four-point scaled score of the animal naming task was added to three-item temporal orientation and three-word recall to compose the 10-point Cognitive Screener. The education-adjusted 10-point Cognitive Screener outperformed the longer Mini-Mental State Examination for detecting both cognitive impairment (area under the curve 0.85 vs 0.77; p = 0.027) and dementia (area under the curve 0.90 vs 0.83; p= 0.015). Conclusions: Based on empirical data, we have developed a brief and easy-to-use screening strategy with higher accuracy and some practical advantages compared with commonly used tools.
Palavras-chave
orientation, memory, verbal fluency, dementia, mild cognitive impairment, screening
Referências
  1. American Psychiatric Association, 1994, DIAGN STAT MAN MENT
  2. Borson S, 2006, INT J GERIATR PSYCH, V21, P349, DOI 10.1002/gps.1470
  3. Grober E, 2008, J INT NEUROPSYCH SOC, V14, P130, DOI 10.1017/S1355617708080156
  4. Wilber ST, 2005, ACAD EMERG MED, V12, P612, DOI 10.1111/j.1553-2712.2005.tb00915.x
  5. Carlson MC, 2009, J GERONTOL A-BIOL, V64, P110, DOI 10.1093/gerona/gln008
  6. Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/01.MLR.0000024610.33213.C8
  7. EBLY EM, 1995, ARCH NEUROL-CHICAGO, V52, P612
  8. Jacinto AF, 2011, CLINICS, V66, P1379, DOI 10.1590/S1807-59322011000800012
  9. O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P746, DOI 10.1001/archneurol.2010.115
  10. Williams BR, 2014, CLIN NEUROPSYCHOL, V28, P505, DOI 10.1080/13854046.2014.897758
  11. MORRIS JC, 1993, NEUROLOGY, V43, P2412
  12. [Anonymous], 2001, ARCH GERONTOL GERIAT, DOI 10.1016/S0167-4943(01)00161-3
  13. Chen MR, 2010, NEUROSCI BULL, V26, P317, DOI 10.1007/s12264-010-0106-1
  14. Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207
  15. Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
  16. GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13
  17. Cordell CB, 2013, ALZHEIMERS DEMENT, V9, P141, DOI 10.1016/j.jalz.2012.09.011
  18. Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964
  19. FILLENBAUM GG, 1994, ARCH NEUROL-CHICAGO, V51, P916
  20. Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6
  21. Carpenter CR, 2011, ANN EMERG MED, V57, P653, DOI 10.1016/j.annemergmed.2010.06.560
  22. Lourenco RA, 2008, REV BRAS PSIQUIATR, V30, P309, DOI 10.1590/S1516-44462008000400002
  23. Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045
  24. GALASKO D, 1990, ARCH NEUROL-CHICAGO, V47, P49
  25. [Anonymous], 1975, J PSYCHIATR RES, DOI 10.1016/0022-3956(75)90026-6
  26. OCONNOR DW, 1988, BRIT MED J, V297, P1107
  27. Abrisqueta-Gomez J, 2008, ALZ DIS ASSOC DIS, V22, P72, DOI 10.1097/WAD.0b013e3181665397
  28. Brucki SMD, 2004, BRAZ J MED BIOL RES, V37, P1771, DOI 10.1590/S0100-879X2004001200002
  29. Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
  30. ASHFORD JW, 1989, J GERONTOL, V44, pP139
  31. Brazilian Association of Research Companies, 2008, BRAZ EC CLASS CRIT
  32. Carnero-Pardo C, 2013, INT J ALZHEIMERS DIS, V2013
  33. Delis D.C., 2000, CALIFORNIA VERBAL LE
  34. DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
  35. Filho STR, 2009, DEMENT NEUROPSYCHOL, V3, P81
  36. SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725